These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15197795)

  • 21. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials.
    Arun B; Valero V; Logan C; Broglio K; Rivera E; Brewster A; Yin G; Green M; Kuerer H; Gong Y; Browne D; Hortobagyi GN; Sneige N
    Clin Cancer Res; 2007 Aug; 13(16):4943-8. PubMed ID: 17699874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of 2,6-cyclolycopene-1,5-diol in breast nipple aspirate fluids and plasma: a potential marker of oxidative stress.
    Chen G; Djuric Z
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1592-6. PubMed ID: 12496049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paget's disease of the nipple in a population based cohort.
    Dalberg K; Hellborg H; Wärnberg F
    Breast Cancer Res Treat; 2008 Sep; 111(2):313-9. PubMed ID: 17952590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.
    Caliskan M; Gatti G; Sosnovskikh I; Rotmensz N; Botteri E; Musmeci S; Rosali dos Santos G; Viale G; Luini A
    Breast Cancer Res Treat; 2008 Dec; 112(3):513-21. PubMed ID: 18240020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.
    Stearns V; Gallagher A; Kleer CG; Singh B; Freedman M; Haddad BR; Isaacs C; Warren R; Brown M; Cullen J; Trock B; Hayes DF
    Clin Cancer Res; 2004 Dec; 10(24):8332-40. PubMed ID: 15623610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fiberoptic ductoscopy findings in women with and without spontaneous nipple discharge.
    Sauter ER; Ehya H; Klein-Szanto AJ; Wagner-Mann C; MacGibbon B
    Cancer; 2005 Mar; 103(5):914-21. PubMed ID: 15666326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.
    Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV
    Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lobular neoplasia on core-needle biopsy--clinical significance.
    Arpino G; Allred DC; Mohsin SK; Weiss HL; Conrow D; Elledge RM
    Cancer; 2004 Jul; 101(2):242-50. PubMed ID: 15241819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytologic features of nipple aspirate fluid using an automated non-invasive collection device: a prospective observational study.
    Proctor KA; Rowe LR; Bentz JS
    BMC Womens Health; 2005 Aug; 5():10. PubMed ID: 16078997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nutritional predictors for cellular nipple aspirate fluid: Nutrition and Breast Health Study.
    Kato I; Ren J; Visscher DW; Djuric Z
    Breast Cancer Res Treat; 2006 May; 97(1):33-9. PubMed ID: 16317581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid.
    Zhu W; Qin W; Bradley P; Wessel A; Puckett CL; Sauter ER
    Carcinogenesis; 2005 Jan; 26(1):145-52. PubMed ID: 15375011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cytomorphology in specimens obtained by random periareolar fine needle aspiration and ductal lavage from women at high risk for development of breast cancer.
    Zalles CM; Kimler BF; Simonsen M; Clark JL; Metheny T; Fabian CJ
    Breast Cancer Res Treat; 2006 May; 97(2):191-7. PubMed ID: 16322885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.
    Goyal A; Douglas-Jones A; Monypenny I; Sweetland H; Stevens G; Mansel RE
    Breast Cancer Res Treat; 2006 Aug; 98(3):311-4. PubMed ID: 16552627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
    Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
    Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
    Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
    Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mammary ductoscopy for evaluation of nipple discharge.
    Kapenhas-Valdes E; Feldman SM; Cohen JM; Boolbol SK
    Ann Surg Oncol; 2008 Oct; 15(10):2720-7. PubMed ID: 18685898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer.
    Adduci KM; Annis CE; DeVries S; Chew KL; Boutin J; Magrane G; Ljung BM; Waldman FM; Esserman LJ
    Cancer; 2007 Jun; 111(3):185-91. PubMed ID: 17474121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.